Leukocytoclastic vasculitis induced by use of glyburide: A case of possible cross-reaction of a sulfonamide and a sulfonylurea

Cutis

Volumn 71, Issue 3, 2003, Pages 235-238

  Bukhalo, Michael ^a   Zeitouni, Nathalie C ^a,b   Cheney, Richard T ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CIPROFLOXACIN; COTRIMOXAZOLE; DIPHENHYDRAMINE; DOXYCYCLINE; FERROUS SULFATE; FUROSEMIDE; GLIBENCLAMIDE; HYDROCODONE; IBUPROFEN; LORATADINE; OMEPRAZOLE; PYRIDOXINE; SERTRALINE; SULFONAMIDE; SULFUR; TERAZOSIN; ANTIDIABETIC AGENT; DIURETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EYELID EDEMA; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; MALE; PAPULE; SKIN BIOPSY; SKIN DEFECT; SKIN EDEMA; ALLERGIC VASCULITIS; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; PATHOLOGY;

ADULT; DIURETICS; DRUG INTERACTIONS; GLYBURIDE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; SULFONAMIDES; SULFONYLUREA COMPOUNDS; VASCULITIS, HYPERSENSITIVITY;

EID: 0037945561     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Braverman IM. Angiitides. In: Braverman IM, ed. Skin Signs of Systemic Disease. 3rd ed. Philadelphia, Pa: WB Saunders; 1998:278-334.
2. Gower RG, Sams WM Jr, Thorne EG, et al. Leukocytoclastic vasculitis - sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol. 1977;69:477-484.
3. Sanchez NP, Van Hale HM, Su WPD. Clinical and histopathologic spectrum of necrotizing vasculitis. Arch Dermatol. 1985;121:220-224.
4. Holtzer CD, Flaherty JF Jr, Coleman RL. Cross-reactivity in HIV-infected patients switched from trimethoprimsulfamethoxazole to dapsone. Pharmacotherapy. 1998;18:831-835.
5. Soter NA. Cutaneous necrotizing vasculitis. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. Vol 2. 5th ed. New York, NY: McGraw-Hill; 1999:2044-2053.
6. Dickey W, Handley J. Purpura, leukocytoclastic vasculitis, and glibenclamide. BMJ. 1980;293:823-824.
7. Clarke BF, Campbell IW. Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy. Diabetes. 1974;23:739-742.
8. Sams MW Jr. Small vessel vasculitis. In: Sams MW Jr, Lynch PJ, eds. Principles and Practice of Dermatology. 2nd ed. New York, NY: Churchill Livingstone; 1996:543-552.